Fisetin is a selective adenosine triphosphate‐competitive inhibitor for mitogen‐activated protein kinase kinase 4 to inhibit lipopolysaccharide‐stimulated inflammation

Ähnliche Einträge

• Nuclear receptor 4A1 (NR4A1) upregulated by n ‐butylidenephthalide via the mitogen‐activated protein kinase ( MAPK) pathway ameliorates drug‐induced gingival enlargement
  von: Tomoya Ueda, et al.
  Veröffentlicht: (2024)
• Agmatine suppresses glycolysis via the PI3K /Akt/ mTOR / HIF ‐1α signaling pathway and improves mitochondrial function in microglia exposed to lipopolysaccharide
  von: Katarina Milosevic, et al.
  Veröffentlicht: (2025)
• High‐fat diet induced obesity promotes inflammation, oxidative stress, and hepatotoxicity in female FVB/N mice
  von: Malvin Ofosu‐Boateng, et al.
  Veröffentlicht: (2024)
• Knockdown of integrin β1 inhibits proliferation and promotes apoptosis in bladder cancer cells
  von: Jin‐feng Wang, et al.
  Veröffentlicht: (2024)
• Correction to “Zerumbone, a ginger sesquiterpene, inhibits migration, invasion, and metastatic behavior of human malignant glioblastoma multiforme in vitro”
  Veröffentlicht: (2025)